Vaxcyte, Inc. Annual Operating Income (Loss) in USD from 2018 to 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Vaxcyte, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2018 to 2023.
  • Vaxcyte, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$140M, a 23.8% decline year-over-year.
  • Vaxcyte, Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$604M, a 68.8% decline year-over-year.
  • Vaxcyte, Inc. annual Operating Income (Loss) for 2023 was -$468M, a 102% decline from 2022.
  • Vaxcyte, Inc. annual Operating Income (Loss) for 2022 was -$232M, a 124% decline from 2021.
  • Vaxcyte, Inc. annual Operating Income (Loss) for 2021 was -$104M, a 15.7% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$468M -$236M -102% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-27
2022 -$232M -$129M -124% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-27
2021 -$104M -$14.1M -15.7% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-27
2020 -$89.6M -$35.4M -65.4% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-27
2019 -$54.2M -$18.6M -52.4% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-28
2018 -$35.5M Jan 1, 2018 Dec 31, 2018 10-K 2021-03-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.